Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period

Acta Obstet Gynecol Scand. 2005 Apr;84(4):402-3. doi: 10.1111/j.0001-6349.2005.00596.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Factor VII / administration & dosage
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Female
  • Hemostatics / administration & dosage
  • Hemostatics / therapeutic use*
  • Humans
  • Injections, Intravenous
  • Postpartum Hemorrhage / drug therapy*
  • Postpartum Hemorrhage / etiology
  • Pregnancy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use*
  • Shock, Hemorrhagic / drug therapy*
  • Shock, Hemorrhagic / etiology
  • Uterine Inertia / complications*

Substances

  • Hemostatics
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa